Hyloris Pharmaceuticals SA (EBR: HYL)
Belgium
· Delayed Price · Currency is EUR 5.60
-0.16 (-2.78%)
Jan 17, 2025, 3:58 PM CET
Hyloris Pharmaceuticals Revenue
Hyloris Pharmaceuticals had revenue of 4.64M EUR in the half year ending June 30, 2024, with 349.18% growth. This brings the company's revenue in the last twelve months to 6.94M, up 112.46% year-over-year. In the year 2023, Hyloris Pharmaceuticals had annual revenue of 4.21M with 76.54% growth.
Revenue (ttm)
6.94M
Revenue Growth
+112.46%
P/S Ratio
23.79
Revenue / Employee
169.29K
Employees
41
Market Cap
162.40M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| argenx SE | 1.71B |
| UCB SA | 5.45B |
| Fagron NV | 820.76M |
| Nyxoah | 5.08M |
| Ion Beam Applications | 465.75M |
| Onward Medical | -188.00K |
| Sequana Medical NV | 433.50K |
| Biocartis Group NV | 60.82M |